134 related articles for article (PubMed ID: 2852652)
1. Toxicologic studies of a superpotent alpha-melanotropin, [Nle4, D-Phe7]alpha-MSH.
Dorr RT; Dawson BV; al-Obeidi F; Hadley ME; Levine N; Hruby VJ
Invest New Drugs; 1988 Dec; 6(4):251-8. PubMed ID: 2852652
[TBL] [Abstract][Full Text] [Related]
2. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
4. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
Kobobun K; O'Donohue TL; Handelmann GE; Sawyer TK; Hruby VJ; Hadley ME
Peptides; 1983; 4(5):721-4. PubMed ID: 6657517
[TBL] [Abstract][Full Text] [Related]
6. Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans.
Dorr RT; Dvorakova K; Brooks C; Lines R; Levine N; Schram K; Miketova P; Hruby V; Alberts DS
Photochem Photobiol; 2000 Oct; 72(4):526-32. PubMed ID: 11045725
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of a melanotropic peptide hormone analogue.
Dawson BV; Hadley ME; Kreutzfeld K; Dorr RT; Hruby VJ; Al-Obeidi F; Don S
Life Sci; 1988; 43(14):1111-7. PubMed ID: 2845208
[TBL] [Abstract][Full Text] [Related]
8. In vitro transdermal delivery of a melanotropic peptide through human skin.
Dawson BV; Hadley ME; Levine N; Kreutzfeld KL; Don S; Eytan T; Hruby VJ
J Invest Dermatol; 1990 Apr; 94(4):432-5. PubMed ID: 2155969
[TBL] [Abstract][Full Text] [Related]
9. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
10. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
11. Alpha-melanocyte-stimulating hormone (MSH) and [Nle4,D-Phe7]-alpha-MSH: effects on core temperature in rats.
Raible LH; Knickerbocker D
Pharmacol Biochem Behav; 1993 Mar; 44(3):533-8. PubMed ID: 8383852
[TBL] [Abstract][Full Text] [Related]
12. Application of an alpha-melanocyte stimulating hormone (alpha-MSH) radioimmunoassay to the detection of the superpotent analog, [Nle4,D-Phe7]-alpha-MSH.
Kreutzfeld KL; Bagnara JT
Pigment Cell Res; 1989; 2(1):65-9. PubMed ID: 2541421
[No Abstract] [Full Text] [Related]
13. Administration of melanotropic peptides during gestation in the rodent.
Dawson BV; Ford CA; Holloway H; Dorr RT; Johnson P
Toxicology; 1993 Jan; 77(1-2):91-101. PubMed ID: 8382846
[TBL] [Abstract][Full Text] [Related]
14. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
[TBL] [Abstract][Full Text] [Related]
15. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH.
Chaturvedi DN; Hruby VJ; Castrucci AM; Kreutzfeld KL; Hadley ME
J Pharm Sci; 1985 Mar; 74(3):237-40. PubMed ID: 2989482
[TBL] [Abstract][Full Text] [Related]
18. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.
Hadley ME; Mieyr JH; Martin BE; Castrucci AM; Hruby VJ; Sawyer TK; Powers EA; Rao KR
Comp Biochem Physiol A Comp Physiol; 1985; 81(1):1-6. PubMed ID: 2859941
[TBL] [Abstract][Full Text] [Related]
19. Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents.
Tatro JB; Reichlin S
Endocrinology; 1987 Nov; 121(5):1900-7. PubMed ID: 2822378
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins.
Chaturvedi DN; Knittel JJ; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1984 Nov; 27(11):1406-10. PubMed ID: 6436488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
